Breakthrough cancer pain and rational drug use
نویسندگان
چکیده
منابع مشابه
Breakthrough cancer pain – still a challenge
Breakthrough cancer pain is defined as transient pain exacerbation in patients with stable and controlled basal pain. Although variable, the prevalence of breakthrough cancer pain is high (33%-95%). According to the American Pain Foundation, breakthrough pain is observed in 50%-90% of all hospitalized cancer patients, in 89% of all patients admitted to homes for the elderly and terminal-patient...
متن کاملPharmacologic management of adult breakthrough cancer pain.
The generally accepted current definition of breakthrough cancer pain (BTCP) is as follows: “a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific and predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain.”1 Spontaneous pain is also referred to as idiopathic pain. Triggers are also referred to as incid...
متن کاملManagement of breakthrough pain due to cancer
Breakthrough pain is defined as the transient exacerbation of pain occurring in a patient with otherwise stable, persistent pain. It is estimated to affect over 50% of patients, particularly those with moderate to severe background pain. Breakthrough pain is one of the most difficult pain syndromes to treat. There are several types of breakthrough cancer pain: incidental type involves flares of...
متن کاملBreakthrough pain in cancer patients: characteristics, prevalence, and treatment.
"Breakthrough pain" is a common clinical term that has not been conclusively defined or described. Breakthrough pain is a transitory flare of pain experienced when baseline pain has been reduced to a mild or moderate level. Breakthrough pain may be characterized by its relationship to a fixed around-the-clock (ATC) opioid dose, rapid onset and short duration, precipitating events, predictabilit...
متن کاملThe use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing.
Breakthrough cancer pain (BTcP) has been defined as a transitory increase in pain intensity on a baseline pain of moderate intensity in patients on analgesic treatment regularly administered. This review provides updated information about the use of opioids for the treatment of BTcP, with special emphasis on the use of new rapid onset opioids (ROOs). Due to its slow onset to effect oral opioids...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Supportive Care in Cancer
سال: 2017
ISSN: 0941-4355,1433-7339
DOI: 10.1007/s00520-017-3636-5